137 related articles for article (PubMed ID: 19139720)
1. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
3. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
5. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blockade ameliorates mesangioproliferative glomerulonephritis in rats through suppression of CTGF and PAI-1, independently of the coagulation system.
Liu N; Shimizu S; Ito-Ihara T; Takagi K; Kita T; Ono T
Nephron Exp Nephrol; 2007; 105(3):e65-74. PubMed ID: 17199095
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
Masuda Y; Shimizu A; Kataoka M; Arai T; Ishikawa A; Du X; Saito SK; Aki K; Nagasaka S; Mii A; Fujita E; Fukuda Y
Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
11. Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis.
Dimmler A; Haas CS; Cho S; Hattler M; Forster C; Peters H; Schöcklmann HO; Amann K
Diagn Mol Pathol; 2003 Jun; 12(2):108-17. PubMed ID: 12766616
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
Takahashi A; Fukusumi Y; Yamazaki M; Kayaba M; Kitazawa Y; Tomita M; Kawachi H
J Nephrol; 2014 Dec; 27(6):627-34. PubMed ID: 25298195
[TBL] [Abstract][Full Text] [Related]
13. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
14. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of angiotensin II-induced extracellular signal regulated kinase-1/2 and -5 in progressive glomerulonephritis.
Nagai T; Urushihara M; Kinoshita Y; Jamba A; Kondo S; Kagami S
Nephrology (Carlton); 2016 Nov; 21(11):950-958. PubMed ID: 26624246
[TBL] [Abstract][Full Text] [Related]
16. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
17. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis.
Ito Y; Kawachi H; Morioka Y; Nakatsue T; Koike H; Ikezumi Y; Oyanagi A; Natori Y; Natori Y; Nakamura T; Gejyo F; Shimizu F
Kidney Int; 2002 Jun; 61(6):2044-57. PubMed ID: 12028445
[TBL] [Abstract][Full Text] [Related]
18. Glomerular repair retardation via blocking of angiotensin II type 1a receptor pathway in a mouse glomerulonephritis model.
Hayashi W; Obata Y; Nishino T; Abe S; Io K; Furusu A; Abe K; Miyazaki M; Sugaya T; Koji T; Kohno S
Nephron Exp Nephrol; 2012; 122(1-2):13-22. PubMed ID: 23446008
[TBL] [Abstract][Full Text] [Related]
19. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
[TBL] [Abstract][Full Text] [Related]
20. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]